{"id":107397,"date":"2026-06-12T10:15:40","date_gmt":"2026-06-12T16:15:40","guid":{"rendered":"https:\/\/trimrx.com\/blog\/wegovy-cost-maine\/"},"modified":"2026-06-12T10:15:40","modified_gmt":"2026-06-12T16:15:40","slug":"wegovy-cost-maine","status":"publish","type":"post","link":"https:\/\/trimrx.com\/blog\/wegovy-cost-maine\/","title":{"rendered":"Wegovy Cost Maine \u2014 Insurance, Coupons, and Savings (2026)"},"content":{"rendered":"<style>\n      .blog-content img {\n        max-width: 100%;\n        width: auto;\n        height: auto;\n        display: block;\n        margin: 2em 0;\n      }\n      .blog-content p {\n        font-size: 18px;\n        line-height: 1.8;\n        margin-bottom: 1.2em;\n        color: #333;\n      }\n      .blog-content ul, .blog-content ol {\n        font-size: 18px;\n        line-height: 1.8;\n        margin: 1.5em 0;\n      }\n      .blog-content li {\n        margin: 0.4em 0;\n      }\n      .blog-content h2 {\n        font-size: 24px;\n        font-weight: 600;\n        margin: 2em 0 0.8em 0;\n        color: #000;\n      }\n      .blog-content h3 {\n        font-size: 20px;\n        font-weight: 600;\n        margin: 1.5em 0 0.6em 0;\n        color: #000;\n      }\n      .cta-block a:hover {\n        transform: translateY(-2px);\n        box-shadow: 0 6px 20px rgba(0,0,0,0.3);\n      }<\/p>\n<\/style>\n<div class=\"blog-content\">\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">Wegovy Cost Maine \u2014 Insurance, Coupons, and Savings (2026)<\/h2>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Wegovy&#39;s wholesale acquisition cost sits at $1,349.02 per 28-day supply across all US markets including Maine\u2014this is the list price Novo Nordisk charges pharmacies before any rebates, insurance contracts, or patient assistance programs apply. That sticker price hasn&#39;t moved since FDA approval in June 2021, but what Maine residents actually pay ranges from $25 copays with commercial insurance to the full $1,349 out-of-pocket when coverage is denied or unavailable.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Our team has worked with hundreds of patients navigating GLP-1 medication access across New England. The cost gap isn&#39;t random\u2014it&#39;s structural. Insurance coverage for anti-obesity medications remains inconsistent in Maine despite federal Medicare expansion in 2026, commercial plans vary wildly in their medical necessity criteria, and manufacturer savings programs carry strict eligibility rules most patients don&#39;t know exist.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\"><strong style=\"font-weight: 700; color: inherit;\">What does Wegovy cost in Maine, and how do residents reduce that price?<\/strong><\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Wegovy costs $1,349.02 per month at list price in Maine. Commercially insured patients typically pay $25\u2013$300 monthly depending on plan formulary tier and medical necessity approval; the Novo Nordisk Wegovy Savings Card reduces copays to $25 for eligible patients but excludes government insurance. Compounded semaglutide\u2014chemically identical but prepared by FDA-registered 503B pharmacies\u2014costs $299\u2013$497 monthly and requires no insurance approval.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">The practical difference between paying $25 and $1,349 for the same medication comes down to three variables: which insurance plan you carry, whether your BMI and comorbidity profile meet medical necessity criteria for coverage, and whether you understand how manufacturer coupons, patient assistance programs, and compounded alternatives stack. This article covers the exact coverage pathways Maine residents use in 2026, the savings programs that reduce cost by $800+ monthly, and when switching to compounded semaglutide makes financial sense.<\/p>\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">Wegovy Pricing Structure in Maine \u2014 Commercial vs Cash Pay<\/h2>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Wegovy&#39;s $1,349.02 wholesale price applies uniformly across Maine whether you fill the prescription at Hannaford, Walgreens, or an independent pharmacy\u2014pharmacies pay Novo Nordisk the same amount per pen pack, and retail markup typically adds $20\u2013$50 to that base. Cash-pay customers see prices between $1,369 and $1,399 depending on the pharmacy&#39;s dispensing fee structure.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Commercially insured patients never pay that list price if coverage is approved. Maine&#39;s dominant commercial insurers\u2014Anthem Blue Cross Blue Shield, Harvard Pilgrim (now Point32Health), and Aetna\u2014negotiate rebates with Novo Nordisk that reduce the net cost by 40\u201365%, but those rebates flow to the insurer, not directly to the patient. Your copay or coinsurance is calculated from the pharmacy&#39;s retail price before rebates, which is why copays can still hit $200\u2013$400 even when the plan covers Wegovy.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Medical necessity requirements are where most coverage denials occur. Anthem&#39;s 2026 formulary requires BMI \u226530 (or \u226527 with one weight-related comorbidity such as type 2 diabetes, hypertension, or obstructive sleep apnea) plus documented failure of behavioral weight loss intervention within the prior 12 months. Harvard Pilgrim&#39;s criteria are slightly more restrictive\u2014they require a 6-month supervised diet and exercise program documented in medical records before approving anti-obesity medications. Patients who meet BMI thresholds but lack that documentation face coverage denial and must either appeal with their prescriber&#39;s support or pay out-of-pocket.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Our experience with Maine patients shows that the prior authorization process\u2014not the medication cost itself\u2014is the bigger access barrier. Plans approve roughly 60% of initial Wegovy requests; denials cite insufficient weight loss attempts, missing comorbidity documentation, or failure to meet specific BMI thresholds at weigh-in. Successful appeals typically require the prescriber to submit treatment notes showing behavioral intervention attempts, comorbidity diagnosis codes (E11.9 for type 2 diabetes, I10 for hypertension), and a letter explaining why Wegovy is medically necessary rather than elective.<\/p>\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">Manufacturer Savings Programs \u2014 The Wegovy Savings Card and Patient Assistance<\/h2>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">The Novo Nordisk Wegovy Savings Card reduces copays to $25 per fill for commercially insured patients whose plans cover Wegovy but assign high cost-sharing\u2014this is the primary cost reduction tool for patients with insurance approval. Eligibility requirements are strict: you must have commercial (non-government) insurance that covers Wegovy, the prescription must be filled at a participating retail pharmacy (not mail-order), and your household income must be below 600% of the federal poverty level (approximately $90,000 for an individual in 2026).<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">The card does not work for patients on Medicare, MaineCare (Medicaid), Tricare, or any state or federal insurance program\u2014this is a legal restriction under federal anti-kickback statutes that prohibit manufacturers from subsidizing government-funded prescriptions. It also does not apply when insurance denies coverage entirely\u2014the card reduces copays only, not the full cash price. Patients whose plans don&#39;t cover Wegovy at all cannot use the savings card to bring the $1,349 price down to $25; they must either appeal the denial or explore alternative pathways.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">The Novo Nordisk Patient Assistance Program (PAP) is the option for uninsured or underinsured patients who cannot afford Wegovy at list price. This program provides Wegovy at no cost to patients with household income below 400% of federal poverty level (approximately $60,000 for an individual) who lack insurance coverage for the medication. Application requires income verification (recent tax return or pay stubs), a prescription from a licensed provider, and completion of the PAP enrollment form with your prescriber&#39;s signature. Processing takes 2\u20134 weeks, and approval is valid for 12 months before re-enrollment is required.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Our team has found that patients often assume the savings card and PAP are interchangeable\u2014they&#39;re not. The savings card works only with active insurance coverage and reduces your copay to $25. The PAP works only without insurance coverage and provides the medication free. Neither program stacks with the other, and neither works for Medicare or MaineCare enrollees, who face unique access constraints we address in the comparison table below.<\/p>\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">Compounded Semaglutide as a Lower-Cost Alternative in Maine<\/h2>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Compounded semaglutide contains the same active molecule as Wegovy (semaglutide at 2.4mg maintenance dose) but is prepared by FDA-registered 503B outsourcing facilities rather than manufactured by Novo Nordisk. The practical difference: compounded versions cost $299\u2013$497 per month with no insurance approval required, no prior authorization delays, and no medical necessity documentation beyond a prescriber&#39;s clinical judgment that the medication is appropriate.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Compounded semaglutide is not FDA-approved as a finished drug product\u2014it falls under a different regulatory pathway. The FDA oversees 503B facilities and inspects them for quality standards, but the agency does not review or approve each compounded batch the way it does for branded Wegovy. The pharmacological mechanism is identical (GLP-1 receptor agonism in the hypothalamus and gut), the dosing schedule is the same (weekly subcutaneous injection titrated from 0.25mg to 2.4mg), and the side effect profile matches clinical trial data for branded semaglutide. What&#39;s different is traceability\u2014if a compounded batch has potency or sterility issues, there&#39;s no formal FDA recall system.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Maine patients typically access compounded semaglutide through telehealth platforms that pair online consultations with a partnered compounding pharmacy. TrimrX operates this model: licensed providers conduct asynchronous consultations, write prescriptions when clinically appropriate (BMI \u226527 with comorbidities or \u226530 without), and ship medication from an FDA-registered 503B facility within 48 hours. Cost is $299\u2013$497 monthly depending on dose tier\u2014no insurance billing, no prior authorization, no appeals process.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">The financial calculus is straightforward for patients whose insurance denies Wegovy coverage or whose copays exceed $300 monthly. Paying $497 for compounded semaglutide costs $852 less per month than the $1,349 Wegovy list price. For patients with insurance approval and a $25 Wegovy copay via the savings card, branded Wegovy is the better value\u2014but that scenario requires (1) plan coverage, (2) prior authorization approval, (3) savings card eligibility, and (4) income below $90,000. Patients who don&#39;t meet all four conditions often find compounded semaglutide the more accessible option.<\/p>\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">Wegovy Cost Maine: Insurance Coverage Comparison<\/h2>\n<div style=\"overflow-x: auto; -webkit-overflow-scrolling: touch; width: 100%; margin-bottom: 8px;\">\n<table style=\"width: auto; min-width: 100%; table-layout: auto; border-collapse: collapse; margin: 24px 0; font-size: 0.95em; box-shadow: 0 2px 4px rgba(0,0,0,0.1);\">\n<thead style=\"background-color: #f8f9fa; border-bottom: 2px solid #dee2e6;\">\n<tr style=\"border-bottom: 1px solid #dee2e6;\">\n<th style=\"padding: 12px 16px; font-weight: 600; color: #212529; text-align: left; min-width: 120px; word-break: break-word; overflow-wrap: break-word;\">Insurance Type<\/th>\n<th style=\"padding: 12px 16px; font-weight: 600; color: #212529; text-align: left; min-width: 120px; word-break: break-word; overflow-wrap: break-word;\">Typical Monthly Cost<\/th>\n<th style=\"padding: 12px 16px; font-weight: 600; color: #212529; text-align: left; min-width: 120px; word-break: break-word; overflow-wrap: break-word;\">Prior Authorization Required?<\/th>\n<th style=\"padding: 12px 16px; font-weight: 600; color: #212529; text-align: left; min-width: 120px; word-break: break-word; overflow-wrap: break-word;\">Savings Card Eligible?<\/th>\n<th style=\"padding: 12px 16px; font-weight: 600; color: #212529; text-align: left; min-width: 120px; word-break: break-word; overflow-wrap: break-word;\">Compounded Alternative Cost<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom: 1px solid #dee2e6;\">\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Commercial (Anthem, Harvard Pilgrim, Aetna) with approval<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">$25\u2013$300 copay<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Yes. BMI \u226530 or \u226527 + comorbidity, documented weight loss attempts<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Yes. Reduces copay to $25 if income &lt;$90k<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">$299\u2013$497. No PA required<\/td>\n<\/tr>\n<tr style=\"border-bottom: 1px solid #dee2e6;\">\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Commercial without approval (coverage denied)<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">$1,349 (full cash price)<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Denial typically due to missing documentation or failed BMI threshold<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">No. Card only works with active coverage<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">$299\u2013$497. No PA required<\/td>\n<\/tr>\n<tr style=\"border-bottom: 1px solid #dee2e6;\">\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Medicare Part D (coverage began Jan 2026)<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">$0\u2013$500+ depending on plan formulary and phase<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Yes. Stricter criteria, often requires 12-month diet documentation<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">No. Federal program exclusion<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">$299\u2013$497. No PA required<\/td>\n<\/tr>\n<tr style=\"border-bottom: 1px solid #dee2e6;\">\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">MaineCare (Medicaid)<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Coverage varies by managed care plan; often denied for weight loss alone<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Yes. Requires comorbidity diagnosis, prior failure of other treatments<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">No. Federal program exclusion<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">$299\u2013$497. No PA required<\/td>\n<\/tr>\n<tr style=\"border-bottom: 1px solid #dee2e6;\">\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Uninsured \/ cash-pay<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">$1,349 list price<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">N\/A<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">No. Requires active insurance<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">$299\u2013$497. Most cost-effective option<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">Key Takeaways<\/h2>\n<ul style=\"font-size: 18px; line-height: 1.8; margin: 1.5em 0; padding-left: 2.5em; list-style-type: disc;\">\n<li style=\"margin-bottom: 0.5em; line-height: 1.8;\">Wegovy&#39;s list price is $1,349.02 per month in Maine, but actual patient cost ranges from $25 (with insurance and savings card) to $1,349 (cash pay without coverage).<\/li>\n<li style=\"margin-bottom: 0.5em; line-height: 1.8;\">The Novo Nordisk Wegovy Savings Card reduces copays to $25 for commercially insured patients with household income below $90,000\u2014it does not work for Medicare, MaineCare, or uninsured patients.<\/li>\n<li style=\"margin-bottom: 0.5em; line-height: 1.8;\">Commercial insurance approval in Maine requires BMI \u226530 (or \u226527 with comorbidities) plus documented behavioral weight loss attempts within the prior 6\u201312 months depending on the plan.<\/li>\n<li style=\"margin-bottom: 0.5em; line-height: 1.8;\">Compounded semaglutide costs $299\u2013$497 monthly from FDA-registered 503B facilities with no prior authorization, no insurance billing, and 48-hour shipping\u2014chemically identical to Wegovy but prepared under a different regulatory pathway.<\/li>\n<li style=\"margin-bottom: 0.5em; line-height: 1.8;\">Medicare Part D began covering anti-obesity medications in January 2026, but prior authorization criteria are stricter than commercial plans, and copays vary widely by plan formulary tier.<\/li>\n<\/ul>\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">What If: Wegovy Cost Maine Scenarios<\/h2>\n<h3 style=\"font-size: 20px; font-weight: 600; margin: 1.5em 0 0.6em 0; line-height: 1.4; color: #000;\">What If My Insurance Denied My Wegovy Prior Authorization?<\/h3>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Appeal the denial with your prescriber&#39;s support\u2014success rates for PA appeals range from 40\u201360% when documentation is strengthened. Your prescriber should submit a letter of medical necessity citing specific comorbidities (type 2 diabetes, hypertension, NAFLD), treatment history showing prior weight loss attempts, and clinical rationale for why Wegovy is appropriate. Include diagnosis codes (E66.9 for obesity, E11.9 for type 2 diabetes) and any lab results showing elevated A1C or liver enzymes. If the appeal fails or you need medication immediately, compounded semaglutide ($299\u2013$497\/month) bypasses the PA process entirely and ships within 48 hours.<\/p>\n<h3 style=\"font-size: 20px; font-weight: 600; margin: 1.5em 0 0.6em 0; line-height: 1.4; color: #000;\">What If I&#39;m on Medicare\u2014Does the Savings Card Work?<\/h3>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">No\u2014the Wegovy Savings Card cannot be used with Medicare Part D or any federal insurance program due to anti-kickback laws. Medicare Part D plans began covering anti-obesity medications in January 2026, but coverage varies by plan, and copays can range from $0 to $500+ depending on formulary tier and whether you&#39;ve reached the catastrophic phase. If your Medicare copay exceeds $300 monthly, compounded semaglutide at $299\u2013$497 is often the lower-cost alternative. TrimrX accepts Medicare patients for telehealth consultations and ships compounded medication without insurance billing.<\/p>\n<h3 style=\"font-size: 20px; font-weight: 600; margin: 1.5em 0 0.6em 0; line-height: 1.4; color: #000;\">What If I Don&#39;t Meet the BMI Threshold but My Doctor Thinks I Need It?<\/h3>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Insurance plans follow strict BMI cutoffs (\u226530, or \u226527 with comorbidities) regardless of clinical judgment\u2014falling below those thresholds results in automatic denial even with prescriber support. Compounded semaglutide operates under prescriber discretion rather than insurance criteria, so providers can prescribe based on clinical need rather than formulary rules. If your BMI is 26 but you have metabolic syndrome or family history of type 2 diabetes, a prescriber working outside insurance constraints can determine whether semaglutide is appropriate for you.<\/p>\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">The Unfiltered Truth About Wegovy Pricing in Maine<\/h2>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Here&#39;s the honest answer: the $1,349 list price is designed to extract maximum revenue from insurance plans\u2014not from patients. Novo Nordisk knows most patients will never pay that amount because commercial insurers negotiate rebates, employer health plans absorb cost-sharing, and government programs now cover the medication under Medicare Part D. The sticker price functions as a negotiating anchor with payers, not a reflection of production cost or fair market value.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Patients caught between coverage denial and unaffordable cash prices are the casualties of this pricing model. If your insurance denies your PA and you don&#39;t qualify for the patient assistance program, Novo Nordisk&#39;s position is effectively <\/p>\n<div class=\"faq-section\" style=\"margin: 3em 0;\" itemscope itemtype=\"https:\/\/schema.org\/FAQPage\">\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 1em 0; color: #000;\">Frequently Asked Questions<\/h2>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">How much does Wegovy cost per month in Maine without insurance?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">Wegovy costs $1,349.02 per month at list price in Maine without insurance. This is the wholesale acquisition cost Novo Nordisk charges pharmacies, and retail markup typically adds $20\u2013$50 to that base, bringing cash-pay prices to $1,369\u2013$1,399 depending on the pharmacy. The Novo Nordisk Patient Assistance Program provides Wegovy at no cost to uninsured patients with household income below $60,000 annually.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">Does MaineCare cover Wegovy for weight loss?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">MaineCare (Maine Medicaid) coverage for Wegovy varies by managed care plan and typically requires prior authorization with documented comorbidities such as type 2 diabetes or cardiovascular disease\u2014coverage for weight loss alone is often denied. Even when approved, the Wegovy Savings Card cannot be used with MaineCare due to federal anti-kickback laws. Patients facing coverage denial or high cost-sharing often access compounded semaglutide at $299\u2013$497 monthly without prior authorization requirements.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">Can I use the Wegovy Savings Card if I have Medicare?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">No\u2014the Wegovy Savings Card cannot be used with Medicare Part D or any federal insurance program due to federal anti-kickback statutes. Medicare Part D plans began covering anti-obesity medications in January 2026, but copays vary widely by plan formulary tier and can range from $0 to $500+ per month. Patients with Medicare copays exceeding $300 often find compounded semaglutide ($299\u2013$497 monthly) the more affordable alternative.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">What is the difference between Wegovy and compounded semaglutide?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">Wegovy and compounded semaglutide contain the same active molecule (semaglutide) and work through identical GLP-1 receptor agonism, but Wegovy is FDA-approved as a finished drug product manufactured by Novo Nordisk, while compounded semaglutide is prepared by FDA-registered 503B facilities under a different regulatory pathway. Compounded versions cost $299\u2013$497 per month with no insurance approval required, whereas Wegovy costs $1,349 at list price or $25\u2013$300 with insurance coverage. The clinical effect and dosing schedule are the same.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">Why did my insurance deny my Wegovy prior authorization?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">Insurance plans in Maine deny Wegovy prior authorizations primarily due to insufficient documentation of behavioral weight loss attempts, failure to meet BMI thresholds (\u226530 or \u226527 with comorbidities), or missing comorbidity diagnosis codes in medical records. Anthem and Harvard Pilgrim require documented diet and exercise programs lasting 6\u201312 months before approving anti-obesity medications. Patients can appeal denials by submitting a prescriber&#8217;s letter of medical necessity with treatment history and comorbidity documentation\u2014success rates are 40\u201360% when documentation is strengthened.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">How do I apply for the Novo Nordisk Patient Assistance Program?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">Apply for the Novo Nordisk Patient Assistance Program by submitting income verification (recent tax return or pay stubs), a valid Wegovy prescription from a licensed provider, and the completed PAP enrollment form with your prescriber&#8217;s signature. Eligibility requires household income below $60,000 annually (400% of federal poverty level) and lack of insurance coverage for Wegovy. Processing takes 2\u20134 weeks, and approval provides medication at no cost for 12 months before re-enrollment is required.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">Can I get Wegovy through telehealth in Maine?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">Yes\u2014Maine residents can access Wegovy through telehealth platforms that conduct remote consultations and coordinate prescription fulfillment. Most platforms require synchronous video or asynchronous questionnaire-based consultations with a licensed provider who evaluates whether semaglutide is clinically appropriate based on BMI, comorbidities, and medical history. If insurance approval is required, patients must still complete prior authorization through their plan; compounded semaglutide through telehealth bypasses insurance entirely and ships within 48 hours at $299\u2013$497 monthly.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">What happens if I stop taking Wegovy\u2014will I regain the weight?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">Clinical evidence shows that most patients regain a significant portion of lost weight after discontinuing semaglutide\u2014the STEP 1 Extension trial found participants regained approximately two-thirds of their lost weight within one year of stopping. This reflects the fact that semaglutide corrects impaired satiety signaling and elevated ghrelin levels, which return when the medication is removed. Patients who achieve goal weight and wish to stop should work with their prescriber to transition to a lower maintenance dose or implement structured dietary adjustments to reduce rebound weight gain.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">Is compounded semaglutide safe and legal in Maine?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">Yes\u2014compounded semaglutide is legal in Maine when prepared by FDA-registered 503B outsourcing facilities or state-licensed compounding pharmacies under USP standards. The FDA currently allows compounding of semaglutide due to ongoing drug shortages of branded Ozempic and Wegovy, which create a clinical need for alternative supply. Compounded semaglutide contains the same active molecule and follows the same dosing protocol as Wegovy, but it is not FDA-approved as a finished drug product. Safety depends on the quality standards of the compounding facility\u2014503B facilities undergo FDA inspection and must meet sterile compounding requirements.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">How much does compounded semaglutide cost compared to Wegovy in Maine?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">Compounded semaglutide costs $299\u2013$497 per month in Maine depending on dose tier, compared to Wegovy&#8217;s $1,349 list price or $25\u2013$300 with insurance and savings card eligibility. For patients whose insurance denies Wegovy coverage or whose copays exceed $300 monthly, compounded semaglutide delivers $852+ in monthly savings while bypassing prior authorization requirements. The medication works through identical GLP-1 receptor agonism and follows the same weekly injection schedule as branded Wegovy.<\/p>\n<\/div>\n<\/details>\n<style>.faq-item summary{outline:none;margin-bottom:0!important;padding-bottom:0!important;}.faq-item summary::-webkit-details-marker{display:none;}.faq-item[open] .faq-arrow{transform:rotate(180deg);}.faq-item>div{margin-top:0!important;padding-top:0!important;}.faq-item p{margin-top:0!important;}<\/style>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Wegovy costs $1,349\/month in Maine without insurance. Our guide covers coverage, manufacturer coupons, and compounded alternatives\u2014saving $800+ monthly.<\/p>\n","protected":false},"author":6,"featured_media":107396,"comment_status":"","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"_yoast_wpseo_title":"Wegovy Cost Maine \u2014 Insurance, Coupons, and Savings (2026)","_yoast_wpseo_metadesc":"Wegovy costs $1,349\/month in Maine without insurance. Our guide covers coverage, manufacturer coupons, and compounded alternatives\u2014saving $800+ monthly.","_yoast_wpseo_focuskw":"wegovy cost maine","footnotes":"","_flyrank_wpseo_metadesc":""},"categories":[1],"tags":[],"class_list":["post-107397","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts\/107397","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/comments?post=107397"}],"version-history":[{"count":0,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts\/107397\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/media\/107396"}],"wp:attachment":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/media?parent=107397"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/categories?post=107397"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/tags?post=107397"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}